Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk
AACE Endocrinology and Diabetes · 2026-05 · 13 (3) · 481-487
DOI: 10.1016/j.aed.2026.02.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift AACE Endocrinology and Diabetes, 2026-05. Verfasst von Jeremy W Winkelman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Scripps Clinic/Scripps Green Hospital, La Jolla, California. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Scripps Clinic/Scripps Green Hospital, La Jolla, California.
- Diabetes and Endocrinology, Scripps Clinic/Scripps Green Hospital, La Jolla, California.
Zitieren
APA
Winkelman, J. W., & Levine, M. J. (2026). Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk. AACE Endocrinology and Diabetes, 13(3), 481-487. https://doi.org/10.1016/j.aed.2026.02.013
Vancouver
Winkelman JW, Levine MJ. Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk. AACE Endocrinology and Diabetes. 2026;13(3):481-487. doi:10.1016/j.aed.2026.02.013
BibTeX
@article{Winkelman2026,
author = {Winkelman, Jeremy W and Levine, Matthew J},
title = {Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {3},
pages = {481--487},
doi = {10.1016/j.aed.2026.02.013}
}
EUVIMED